Answers are grounded in this paper and cite their sources.
Late blight of potato, caused by Phytophthora infestans , is the most significant and dangerous disease of potatoes, leading to annual losses of billions of dollars worldwide. Two Trichoderma strains were investigated for their use as biological control organisms of this disease under both in vitro and greenhouse environments. On the basis of these results, the Trichoderma virens strain AY154945 Ir. 11 presented a more specific response to P. infestans than did the other strain AY154931, a T. koningii Ir. 502 strain. Moreover, the T. virens Ir. 11 AY154945 exhibited the highest activity in inhibiting P. infestans growth, reaching up to 86.6% reduction under in vitro conditions. Additionally, the results indicated that treatment with T. virens Ir. 11 significantly reduced hydrogen peroxide levels. In greenhouse-grown potato plants challenged with P. infestans , treatment with T. virens Ir. 11 reduced H 2 O 2 levels by 48.07% and 31.37% in Agria and Jelly, respectively, compared with P. infestans -infected plants. The treatment also increased total phenolic content by 60.13% in Agria compared with P. infestans -infected plants. PAL activity increased by 20.77% and 21.59% in Agria and Jelly, respectively, compared with P. infestans -infected plants. Furthermore, compared with plants treated with P. infestans alone, treatment with T. virens Ir. 11, increased the expression of StuPR1 by 3.27-fold and 1.72-fold in Agria and Jelly, respectively; StuMAPK4 by 3.07-fold and 3.19-fold; StuPPO9 by 2.08-fold and 1.80-fold; and StuPAL by 2.89-fold and 1.91-fold, respectively. Overall, T. virens Ir. 11 induced stronger defense-related responses, whereas the other Trichoderma strain showed different responses. The results showed that potato cultivars differed in their precise responses to Trichoderma treatments. On the basis of these findings, a comprehensive evaluation of the impact of Trichoderma as a biological fungicide on each potato cultivar before its utilization in commercial fields is imperative.
No takes yet. Share an insight, caveat, or question.
Akbari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: